Bausch Health Companies | VRX - Ebitda

Preço das Ações
7.79
Mudança Diária
-0.10 -1.21%
Mensal
-1.33%
Anual
16.37%
Q2 Previsão
7.72




Ebitda Alterar Data
Amgen USD 5.14B 775M 2025-12
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Aurora Cannabis CAD 18.48M 3.11M 2025-12
Bausch Health Companies USD 837M 94M 2026-03
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -2.87M 19.49M 2025-12
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Danaher USD 1.92B 204M 2026-03
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novo Nordisk DKK 34.72B 2.57B 2026-03
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 90.82M 3.99M 2025-12
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.39B 48.8M 2025-12
Zoetis USD 939M 101M 2025-12